IL198291A0 - Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases - Google Patents
Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseasesInfo
- Publication number
- IL198291A0 IL198291A0 IL198291A IL19829109A IL198291A0 IL 198291 A0 IL198291 A0 IL 198291A0 IL 198291 A IL198291 A IL 198291A IL 19829109 A IL19829109 A IL 19829109A IL 198291 A0 IL198291 A0 IL 198291A0
- Authority
- IL
- Israel
- Prior art keywords
- medicament
- prevention
- preparation
- treatment
- autoimmune diseases
- Prior art date
Links
- 208000023275 Autoimmune disease Diseases 0.000 title 1
- 108010078233 Thymalfasin Proteins 0.000 title 1
- 102400000800 Thymosin alpha-1 Human genes 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- NZVYCXVTEHPMHE-ZSUJOUNUSA-N thymalfasin Chemical compound CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NZVYCXVTEHPMHE-ZSUJOUNUSA-N 0.000 title 1
- 229960004231 thymalfasin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000584A ITRM20060584A1 (it) | 2006-10-27 | 2006-10-27 | Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni |
| PCT/IT2007/000677 WO2008050363A2 (en) | 2006-10-27 | 2007-09-27 | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL198291A0 true IL198291A0 (en) | 2011-08-01 |
Family
ID=39322489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL198291A IL198291A0 (en) | 2006-10-27 | 2009-04-22 | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100004174A1 (enExample) |
| EP (1) | EP2086569A2 (enExample) |
| JP (1) | JP2010507650A (enExample) |
| KR (1) | KR20090096688A (enExample) |
| CN (1) | CN101534853A (enExample) |
| AU (1) | AU2007310416A1 (enExample) |
| BR (1) | BRPI0718010A2 (enExample) |
| CA (1) | CA2666609A1 (enExample) |
| EA (1) | EA200900602A1 (enExample) |
| IL (1) | IL198291A0 (enExample) |
| IT (1) | ITRM20060584A1 (enExample) |
| MX (1) | MX2009004196A (enExample) |
| WO (1) | WO2008050363A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100248272A1 (en) * | 2009-03-31 | 2010-09-30 | Cornell University | Method for identifying Smk box riboswitch modulating compounds |
| WO2025078961A1 (en) * | 2023-10-13 | 2025-04-17 | Gufic Biosciences Limited | Composition and method for treatment of endometriosis |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5852225A (ja) * | 1981-09-22 | 1983-03-28 | Mitsui Pharmaceut Inc | 脱髄疾患治療剤 |
| US4444757A (en) * | 1981-11-16 | 1984-04-24 | Research Corporation | Use of thymosin as an anti-diabetes and anti-hypertensive disease agent |
| TW249754B (enExample) * | 1993-10-26 | 1995-06-21 | Alpha I Biomedicals Inc | |
| US5888980A (en) * | 1994-06-30 | 1999-03-30 | Bio-Logic Research And Development Corporation | Compositions for enhancing immune function |
| CA2270223A1 (en) * | 1996-10-28 | 1998-05-07 | Carson B. Burgstiner (Deceased) | Methods and compositions for dietary supplementation |
| CN1198950A (zh) * | 1998-04-24 | 1998-11-18 | 崔泊 | 一种结肠炎新药的制备 |
| CN1628796A (zh) * | 2004-08-20 | 2005-06-22 | 康合堂 | 一种治疗溃疡性结肠炎的药物 |
-
2006
- 2006-10-27 IT IT000584A patent/ITRM20060584A1/it unknown
-
2007
- 2007-09-27 JP JP2009534061A patent/JP2010507650A/ja active Pending
- 2007-09-27 BR BRPI0718010-1A patent/BRPI0718010A2/pt not_active IP Right Cessation
- 2007-09-27 CN CNA200780040140XA patent/CN101534853A/zh active Pending
- 2007-09-27 WO PCT/IT2007/000677 patent/WO2008050363A2/en not_active Ceased
- 2007-09-27 MX MX2009004196A patent/MX2009004196A/es not_active Application Discontinuation
- 2007-09-27 AU AU2007310416A patent/AU2007310416A1/en not_active Abandoned
- 2007-09-27 EA EA200900602A patent/EA200900602A1/ru unknown
- 2007-09-27 EP EP07827728A patent/EP2086569A2/en not_active Withdrawn
- 2007-09-27 CA CA002666609A patent/CA2666609A1/en not_active Abandoned
- 2007-09-27 KR KR1020097007708A patent/KR20090096688A/ko not_active Withdrawn
- 2007-09-27 US US12/446,670 patent/US20100004174A1/en not_active Abandoned
-
2009
- 2009-04-22 IL IL198291A patent/IL198291A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008050363A8 (en) | 2009-06-04 |
| WO2008050363A2 (en) | 2008-05-02 |
| MX2009004196A (es) | 2009-06-30 |
| WO2008050363A3 (en) | 2008-06-26 |
| CA2666609A1 (en) | 2008-05-02 |
| CN101534853A (zh) | 2009-09-16 |
| JP2010507650A (ja) | 2010-03-11 |
| EA200900602A1 (ru) | 2009-10-30 |
| BRPI0718010A2 (pt) | 2013-11-19 |
| EP2086569A2 (en) | 2009-08-12 |
| US20100004174A1 (en) | 2010-01-07 |
| KR20090096688A (ko) | 2009-09-14 |
| AU2007310416A1 (en) | 2008-05-02 |
| ITRM20060584A1 (it) | 2008-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249165A0 (en) | Use of an antigen-mhc complex to prepare drugs for the prevention and treatment of autoimmune conditions | |
| IL177914A0 (en) | Use of indazolecarboxamide derivatives for the preparation of a medicament that is intended for the treatment and prevention of paludism | |
| IL200278A (en) | Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness | |
| ZA200703601B (en) | Medicaments for the treatment or prevention of fibriotic diseases | |
| IL199045A0 (en) | Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases | |
| IL180565A0 (en) | An improved stopcock for administering medicaments into the patient's body | |
| IL207439B (en) | Use of an antagonistic antibody against calcitonin gene-related peptide (cgrp) for the preparation of a drug for the prevention and/or treatment of joint pain | |
| IL182105A0 (en) | Use of memantine for the preparation of a medicament for the treatment of childhood behavioral disorders | |
| IL222879A (en) | Peptides and their use in the treatment and diagnosis of diseases and pharmaceutical preparations containing them | |
| IL190284A (en) | Use of milenzipran, or a suitable pharmaceutical salt, in the preparation of a drug for the treatment of fibromyalgia | |
| IL184037A0 (en) | Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis | |
| IL193094A (en) | Appalidine and other drugs used in the manufacture of a cancer treatment drug when the combination of the two gives a synergistic result | |
| IL189162A0 (en) | Use of hydroxybenzoic acid ester and analogues for the manufacture of a medicament for the prevention and treatment of virus infection | |
| IL183929A0 (en) | Use of inerferon - ?? in the preparation of a medicament | |
| GB2443336B (en) | Spiruchostatin analogues and their medicinal use | |
| IL184124A0 (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| IL192600A (en) | Use of thymosin b4 polypeptides for the preparation of drugs for the treatment and prevention of tissue damage caused by increased blood flow | |
| ZA201003037B (en) | Use of 3, 11b-cis-dihydrotettabenazine in the treatment of multiple sclerosis and autoimmune myelitis | |
| IL181819A (en) | Use of Benzo-compound compounds for the preparation of pharmaceuticals and the uses of these @ compounds | |
| IL195955A0 (en) | Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma | |
| IL198291A0 (en) | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases | |
| IL177609A (en) | Use of gobacoline or its analogue to produce a drug to treat liver carcinoma | |
| EP2065049A4 (en) | USE OF SOLIDAGO VIRGAUREA IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT AND PREVENTION OF A VIRUS | |
| IL198290A0 (en) | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies | |
| ZA200900257B (en) | Use of thymosin Alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma |